SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-17-002711
Filing Date
2017-03-20
Accepted
2017-03-20 15:00:51
Documents
1
Period of Report
2017-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K/A ALEXION MARCH 2017 alexionmarch20178-ka.htm 8-K/A 35526
  Complete submission text file 0001628280-17-002711.txt   36754
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34949 | Film No.: 17701223
SIC: 2834 Pharmaceutical Preparations